STAGE IV BREAST CANCER
Clinical trials for STAGE IV BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IV BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE IV BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to train immune system against breast cancer stem cells
⭐️ VACCINE ⭐️ OngoingThis early-stage trial tests a DNA vaccine called STEMVAC in 42 people with advanced HER2-negative breast cancer whose disease is stable or gone after standard treatment. The vaccine is designed to help the immune system recognize and attack cancer stem cells, which are often res…
Matched conditions: STAGE IV BREAST CANCER
Phase: PHASE1 • Sponsor: University of Washington • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:06 UTC
-
New hope for Hard-to-Treat breast cancer: immune cocktails enter trial
Disease control OngoingThis phase 2 trial tests whether combining immunotherapy (avelumab) with other drugs can shrink tumors in people with advanced triple-negative breast cancer that has spread or come back. About 145 participants will receive one of several drug combinations, including avelumab plus…
Matched conditions: STAGE IV BREAST CANCER
Phase: PHASE2 • Sponsor: Laura Huppert, MD, BA • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New drug shows promise in slowing advanced breast cancer
Disease control OngoingThis phase 3 study tests whether the drug sacituzumab govitecan (Trodelvy) can help people with a common type of advanced breast cancer (HR+/HER2-) live longer without their cancer growing. About 654 participants will receive either the new drug or one of three standard chemother…
Matched conditions: STAGE IV BREAST CANCER
Phase: PHASE3 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New PET scan may predict breast cancer drug success
Diagnosis OngoingThis study tested whether a special PET scan using a radioactive tracer can predict how well patients with advanced HER2-positive breast cancer respond to the drug T-DM1. Ten women with cancer that had spread to other parts of the body received the scan before treatment. The goal…
Matched conditions: STAGE IV BREAST CANCER
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
New imaging tracer could sharpen detection of aggressive breast cancer
Diagnosis OngoingThis pilot study tests a special PET scan using a radioactive tracer called 64Cu-DOTA-trastuzumab in 18 women with advanced HER2-positive breast cancer. The goal is to see if this scan can better identify HER2-positive tumors compared to standard imaging. If it works, it may help…
Matched conditions: STAGE IV BREAST CANCER
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC